Homing Peptides for Cancer Therapy

Area of Science:

• Biomedical Engineering
• Molecular Biology
• Pharmacology

Background:

• Tumor-homing peptides improve selectivity of anticancer drugs and imaging agents.
• Targeting aims to increase tumor uptake and reduce off-target accumulation.

Purpose of the Study:

• Provide an overview of tumor-homing peptide identification and validation.
• Discuss preclinical and clinical development of various peptide classes.
• Highlight C-end Rule (CendR) peptides for extravascular tumor targeting.

Main Methods:

• Review of current literature on peptide identification and validation.
• Analysis of preclinical and clinical data for peptide-based therapeutics.
• Focus on mechanistic features of CendR peptides.

Main Results:

• Established methods for identifying and validating tumor-homing peptides.
• Overview of diverse peptide classes in development.
• Demonstrated potential of CendR peptides for tissue penetration.

Conclusions:

• Peptide-guided smart drugs and imaging agents represent a promising area of cancer therapy.
• Further research is needed to address unanswered questions in peptide development.
• CendR peptides offer a novel strategy for targeting extravascular tumor tissues.